PET using new agent is better for CAD diagnosis than SPECT:

06/10/2010 | HealthImaging.com

PET using the experimental agent BMS747158 yielded better images than technetium-99m sestamibi SPECT in the diagnosis of coronary artery disease, a Phase II study showed. The PET method also pinpointed a bigger perfusion defect area than identified by SPECT imaging, according to the study.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA